Legg Mason Asset Management’s Qualcomm QCOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$722K Sell
3,948
-197
-5% -$31.5K 0.8% 61
2021
Q3
$535K Buy
+4,145
New +$588K 0.62% 86
2017
Q4
Sell
-54,400
Closed -$2.82M 132
2017
Q3
$2.82M Buy
54,400
+17,900
+49% +$947K 1.67% 14
2017
Q2
$2.02M Buy
36,500
+22,000
+152% +$1.23M 1.66% 7
2017
Q1
$832K Sell
14,500
-1,000
-6% -$58K 0.96% 57
2016
Q4
$1.01M Buy
+15,500
New +$1.04M 1.16% 44
2015
Q1
Sell
-19,800
Closed -$1.47M 139
2014
Q4
$1.47M Sell
19,800
-2,500
-11% -$183K 1.11% 17
2014
Q3
$1.67M Buy
22,300
+7,500
+51% +$574K 1.17% 20
2014
Q2
$1.17M Sell
14,800
-1,300
-8% -$103K 0.74% 59
2014
Q1
$1.27M Sell
16,100
-1,800
-10% -$136K 0.75% 58
2013
Q4
$1.33M Sell
17,900
-3,300
-16% -$233K 0.77% 61
2013
Q3
$1.43M Sell
21,200
-1,900
-8% -$125K 0.77% 60
2013
Q2
$1.41M Buy
+23,100
New +$1.47M 0.76% 56

Other funds holding QCOM

Legg Mason Asset Management's QCOM Position: Q4 2021 in Review

Legg Mason Asset Management reduced its Qualcomm (QCOM) stake by 4.8% in Q4 2021, selling an estimated $31.5K and leaving 3,948 shares worth $722K. The position accounts for 0.8% of the portfolio, ranked #61.

Legg Mason Asset Management first reported a position in QCOM in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.82M in Q3 2017. 2,463 funds tracked by Wall St. Rank hold QCOM as of Q4 2021.

  • Legg Mason Asset Management held 3,948 shares of Qualcomm worth $722K as of Q4 2021.
  • Legg Mason Asset Management sold 197 Qualcomm shares in Q4 2021, an estimated $31.5K.
  • Qualcomm made up 0.8% of Legg Mason Asset Management's portfolio in Q4 2021, its #61 holding.
  • Legg Mason Asset Management first reported a position in Qualcomm in Q2 2013 and has held it in 13 quarters since.
  • Legg Mason Asset Management's Qualcomm position peaked at $2.82M in Q3 2017.
  • 2,463 funds tracked by Wall St. Rank held Qualcomm as of Q4 2021.

Based on Legg Mason Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.